NSC |
Compound |
Enrichment |
Correlation |
NSC 624512 |
Null |
0.0100995289754787 |
0.67295103 |
NSC 629910 |
Null |
0.0100995289754787 |
0.19734179 |
NSC 649307 |
Null |
0.0100995289754787 |
0.29378689 |
NSC 667707 |
Null |
0.0100995289754787 |
0.068665334 |
NSC 671392 |
Null |
0.0100995289754787 |
0.42625467 |
NSC 676779 |
Olean-12-en-28-oic acid, 3-.beta.-[3-O-(.beta.-L-arabinopyranosyl)- 6-methyl-.beta.-D-glucopyranuronosyloxy]-, [2-O-[[4-O-[3-O-(.beta.-L-arabinopyranosyl)- .beta.-D-xylopyranosyl]-3-O-(.beta.-D-xylop |
0.0100995289754787 |
0.18648982 |
NSC 678925 |
1-Phenazinecarboxamide, N-[2-(dimethylamino)ethyl]- 9-fluoro-, monohydrochloride |
0.0100995289754787 |
0.32636607 |
NSC 682764 |
Pyrido[3,2-d][1]benzazepin-6-one, 4-(4-chlorophenyl)-2-phenyl- |
0.0100995289754787 |
-0.19478077 |
NSC 690270 |
ANTINEOPLASTIC-690270 |
0.0100995289754787 |
0.32144458 |
NSC 697166 |
4H-1,2,4-Triazol-4-amine, 3,3'-(1,8-octanediyl)bis[5-[(4-chlorophenoxy)methyl]- N-phenyl- |
0.0100995289754788 |
0.25329585 |